Indivior Pharmaceuticals, Inc. (INDV) Operating margin 2022–2025
Indivior Pharmaceuticals, Inc. (INDV) operating margin by fiscal year — reported operating income divided by reported revenue.
21.1%FY2025 · since FY2022: -8.5% → 21.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 21.1% | +17.9 pp |
| FY2024 | 3.2% | +17.1 pp |
| FY2023 | -13.9% | -5.4 pp |
| FY2022 | -8.5% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More INDV financial trends
INDV RevenueINDV Net incomeINDV Net marginINDV Gross profitINDV Gross marginINDV Operating incomeINDV Operating cash flowINDV Free cash flowINDV Capital expendituresINDV Return on equityINDV Stock buybacksINDV Dividends paidINDV Total assetsINDV Total liabilitiesINDV Shareholders’ equityINDV overview →